GlassScriptPhysician profile
Rae Buckley
NPI 1063931426
$1,064.39
in general payments reported to CMS, 2019-2025
10 companies · $18.05 in 2025
The $18.05 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $106 · 2022: $386 · 2023: $169 · 2024: $385 · 2025: $18.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $572.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $571.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $293.73 | 2023-2025 | |
| Smith+Nephew, INC. | $226.08 | 2021-2022 | |
| Allergan, INC. | $121.39 | 2022 | |
| Davol INC. | $120.81 | 2022 | |
| Ethicon US, LLC | $76.23 | 2024 | Stratafix |
| Polynovo North America LLC | $61.43 | 2024 | Novosorb Btm |
| Kci USA, INC. | $46.16 | 2022-2023 | Activ.A.C. |
| Avita Medical Americas, LLC | $44.23 | 2024 | |
| Solventum Corporation | $42.18 | 2024 | Activ.A.C., Prevena |
| Integra Lifesciences Corporation | $32.15 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rae Buckley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.